While the sports nutrition market appears to be booming, it is important to keep reality in check. In our first ever sports nutrition survey we ask how market forces, regulations, and innovation are impacting the market. There's just three days left...
Belgian flavour and ingredient firm Frutarom Health is targeting APAC expansion with its cosmeceutical products, starting with its most recent launch, PhytoflORAL.
Health and Happiness (H&H) achieved a revenue of RMB4573.6m (about US$669m) in the first half of 2018, which is 28.8% higher than the same period last year.
Are there reasons for sports nutrition firms to panic over Brexit? How likely will a trade deal be agreed that avoids tariffs and bureaucracy? And how can firms prepare for a new market and policy environment?
DSM has appointed Salutivia as UK distributor for its range of vitamins, carotenoids, and essential fatty acids in a deal that plays to Salutivia’s strengths in the supplement and food ingredient markets.
US-based Archer Daniels Midland (ADM) has completed its acquisition of UK-based Probiotics International Limited - known under its umbrella brand Protexin.
Riding on the ‘clean label’ sports nutrition movement, beverage giant Coca-Cola announced that it is acquiring a minority stake in BodyArmor, structured to lead to a full acquisition.
UK-based nutritional ingredient supplier Cambridge Commodities limited (CCL) has acquired the ingredient business of US-based raw and organic superfood wholesaler, Earth Circle Organics.
French-based biotech start-up Nextbiotix has successfully raised €7m in a Series A financing round, to develop microbiome-based approaches that address inflammatory bowel disease (IBD).
Health & Happiness International (H&H, formerly Biostime International) — and owner of Swisse — has announced it is seeking a loan of up to US$350m through Goldman Sachs.
LabCorp announced today that it has entered a definitive agreement to sell its Covance Food Solutions business to Eurofins Scientific for $670 million.
A change to how initiatives that tackle malnutrition are funded is overdue after a paper reveals an additional €19bn ($23.25bn) is needed each year until 2030 to meet Sustainable Development Goals (SDGs).
Novartis will sell its stake in a consumer healthcare joint venture to partner GSK and plans to invest the $13bn into its core pharmaceutical businesses.
Chinese investment into Australian health firms, including supplement manufacturers, will continue to grow as the country's healthcare system matures and the population ages, analysts from KPMG are forecasting.
